{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:52:05Z","timestamp":1793069525270,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS098819"],"award-info":[{"award-number":["R01NS098819"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AGRDTD03-25-2022"],"award-info":[{"award-number":["AGRDTD03-25-2022"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37NS040389"],"award-info":[{"award-number":["R37NS040389"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS117910"],"award-info":[{"award-number":["R01NS117910"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG 066507"],"award-info":[{"award-number":["P30AG 066507"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.celrep.2025.116741","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:28:52Z","timestamp":1766183332000},"page":"116741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Repeat-associated non-AUG translation as a common mechanism for the polyGln ataxias"],"prefix":"10.1016","volume":"45","author":[{"given":"Monica","family":"Banez-Coronel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadan","family":"Ajredini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis B.","family":"Tays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Duvick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pletnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.","family":"Yachnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Troncoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry L.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley S.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Ashizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.H.","family":"Subramony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry T.","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9808-9661","authenticated-orcid":false,"given":"Laura P.W.","family":"Ranum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.116741_bib1","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.neuron.2023.09.036","article-title":"HD and SCA1: Tales from two 30-year journeys since gene discovery","volume":"111","author":"Thompson","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrn.2017.92","article-title":"Polyglutamine spinocerebellar ataxias - from genes to potential treatments","volume":"18","author":"Paulson","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.celrep.2025.116741_bib3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neuron.2011.05.027","article-title":"CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA","volume":"70","author":"Sopher","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib4","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1093\/hmg\/ddr263","article-title":"A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression","volume":"20","author":"Chung","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2025.116741_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ana.24761","article-title":"ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis","volume":"80","author":"Li","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2025.116741_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/genes11121418","article-title":"Antisense Transcription across Nucleotide Repeat Expansions in Neurodegenerative and Neuromuscular Diseases: Progress and Mysteries","volume":"11","author":"Castro","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.celrep.2025.116741_bib7","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2017.08.039","article-title":"RAN Translation Regulated by Muscleblind Proteins in Myotonic Dystrophy Type 2","volume":"95","author":"Zu","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib8","doi-asserted-by":"crossref","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","article-title":"RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia","volume":"110","author":"Zu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116741_bib9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.molcel.2005.09.002","article-title":"Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF","volume":"20","author":"Cho","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.116741_bib10","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1093\/hmg\/ddm293","article-title":"An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals","volume":"16","author":"Ladd","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2025.116741_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1073\/pnas.1013343108","article-title":"Non-ATG-initiated translation directed by microsatellite expansions","volume":"108","author":"Zu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116741_bib12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","article-title":"The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS","volume":"339","author":"Mori","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116741_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","article-title":"Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS","volume":"77","author":"Ash","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","article-title":"CGG Repeat-Associated Translation Mediates Neurodegeneration in Fragile X Tremor Ataxia Syndrome","volume":"78","author":"Todd","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.neuron.2015.10.038","article-title":"RAN Translation in Huntington Disease","volume":"88","author":"Banez-Coronel","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.conb.2021.11.001","article-title":"RAN proteins in neurodegenerative disease: Repeating themes and unifying therapeutic strategies","volume":"72","author":"Guo","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.celrep.2025.116741_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41374-019-0241-x","article-title":"Repeat-associated non-AUG (RAN) translation: insights from pathology","volume":"99","author":"Banez-Coronel","year":"2019","journal-title":"Lab. Invest."},{"key":"10.1016\/j.celrep.2025.116741_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107616","article-title":"Hexanucleotide Repeat Expansions in c9FTD\/ALS and SCA36 Confer Selective Patterns of Neurodegeneration In Vivo","volume":"31","author":"Todd","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116741_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn2321","article-title":"AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons","volume":"10","author":"Maltby","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2025.116741_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2416885122","article-title":"CASP8 intronic expansion identified by poly-glycine-arginine pathology increases Alzheimer's disease risk","volume":"122","author":"Nguyen","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116741_bib21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neuron.2019.11.007","article-title":"Antibody Therapy Targeting RAN Proteins Rescues C9 ALS\/FTD Phenotypes in C9orf72 Mouse Model","volume":"105","author":"Nguyen","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.neuron.2020.09.009","article-title":"Survival and Motor Phenotypes in FVB C9-500 ALS\/FTD BAC Transgenic Mice Reproduced by Multiple Labs","volume":"108","author":"Nguyen","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.neuron.2016.04.005","article-title":"C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS\/FTD","volume":"90","author":"Liu","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib24","doi-asserted-by":"crossref","first-page":"18591","DOI":"10.1073\/pnas.2005748117","article-title":"Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS\/FTD mice","volume":"117","author":"Zu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116741_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fnmol.2017.00035","article-title":"The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD","volume":"10","author":"Freibaum","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.celrep.2025.116741_bib26","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1126\/science.1256800","article-title":"C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins","volume":"345","author":"Mizielinska","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116741_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neuron.2016.09.015","article-title":"Poly(GR) in C9ORF72-Related ALS\/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons","volume":"92","author":"Lopez-Gonzalez","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-neuro-070918-050405","article-title":"Repeat-Associated Non-ATG Translation: Molecular Mechanisms and Contribution to Neurological Disease","volume":"42","author":"Nguyen","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.celrep.2025.116741_bib29","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899023","article-title":"SCA8 RAN polySer protein preferentially accumulates in white matter regions and is regulated by eIF3F","volume":"37","author":"Ayhan","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2025.116741_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuroimage.2008.06.036","article-title":"Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics","volume":"43","author":"Della Nave","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.celrep.2025.116741_bib31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/brain\/aws369","article-title":"Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6","volume":"136","author":"Reetz","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2025.116741_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fneur.2020.00411","article-title":"Assessment of Cerebral and Cerebellar White Matter Microstructure in Spinocerebellar Ataxias 1, 2, 3, and 6 Using Diffusion MRI","volume":"11","author":"Park","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.celrep.2025.116741_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00415-013-7186-6","article-title":"White matter damage is related to ataxia severity in SCA3","volume":"261","author":"Kang","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.celrep.2025.116741_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135449","article-title":"Extensive White Matter Alterations and Its Correlations with Ataxia Severity in SCA 2 Patients","volume":"10","author":"Hernandez-Castillo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2025.116741_bib35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1017\/S1355617716000084","article-title":"Cognitive Deficits Correlate with White Matter Deterioration in Spinocerebellar Ataxia Type 2","volume":"22","author":"Hernandez-Castillo","year":"2016","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.celrep.2025.116741_bib36","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.3174\/ajnr.A4903","article-title":"Ataxia Severity Correlates with White Matter Degeneration in Spinocerebellar Ataxia Type 7","volume":"37","author":"Hernandez-Castillo","year":"2016","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.celrep.2025.116741_bib37","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s12311-024-01681-2","article-title":"Correction: Cerebellar Volumetry in Ataxias: Relation to Ataxia Severity and Duration","volume":"23","author":"Ferreira","year":"2024","journal-title":"Cerebellum"},{"key":"10.1016\/j.celrep.2025.116741_bib38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/18715273113126660170","article-title":"A friend in need may not be a friend indeed: role of microglia in neurodegenerative diseases","volume":"12","author":"Kaushik","year":"2013","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.celrep.2025.116741_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.celrep.2025.116741_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","article-title":"Microglial physiology: unique stimuli, specialized responses","volume":"27","author":"Ransohoff","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.116741_bib41","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.celrep.2025.116741_bib42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0896-6273(02)00733-X","article-title":"A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration","volume":"34","author":"Watase","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172632","article-title":"Identifying Disease Signatures in the Spinocerebellar Ataxia Type 1 Mouse Cortex","volume":"11","author":"Luttik","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.celrep.2025.116741_bib44","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","article-title":"YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit","volume":"11","author":"Cemal","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2025.116741_bib45","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.neuron.2018.02.013","article-title":"ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism","volume":"97","author":"Rousseaux","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib46","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1101\/gad.212068.112","article-title":"Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein Ataxin-1 and Capicua","volume":"27","author":"Kim","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2025.116741_bib47","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41419-021-04404-1","article-title":"Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy","volume":"12","author":"Marcelo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2025.116741_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6701793","article-title":"Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells","volume":"2016","author":"Ou","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.celrep.2025.116741_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/neup.12433","article-title":"Deregulation of autophagy in postmortem brains of Machado-Joseph disease patients","volume":"38","author":"Sittler","year":"2018","journal-title":"Neuropathology"},{"key":"10.1016\/j.celrep.2025.116741_bib50","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-014-1289-8","article-title":"The autophagy\/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice","volume":"128","author":"Alves","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.116741_bib51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410390214","article-title":"Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions","volume":"39","author":"Gilman","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2025.116741_bib52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pneurobio.2011.08.013","article-title":"Autophagy and polyglutamine diseases","volume":"97","author":"Jimenez-Sanchez","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.celrep.2025.116741_bib53","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nm.4335","article-title":"Metformin ameliorates core deficits in a mouse model of fragile X syndrome","volume":"23","author":"Gantois","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116741_bib54","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cge.13039","article-title":"Metformin as targeted treatment in fragile X syndrome","volume":"93","author":"Dy","year":"2018","journal-title":"Clin. Genet."},{"key":"10.1016\/j.celrep.2025.116741_bib55","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2006.10.039","article-title":"Metformin therapy in a transgenic mouse model of Huntington's disease","volume":"411","author":"Ma","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.celrep.2025.116741_bib56","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38744","article-title":"Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease","volume":"7","author":"Arnoux","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2025.116741_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0264-9","article-title":"Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease","volume":"51","author":"Sanchis","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celrep.2025.116741_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179283","article-title":"Metformin intake associates with better cognitive function in patients with Huntington's disease","volume":"12","author":"Hervas","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2025.116741_bib59","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1093\/brain\/awy231","article-title":"Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial","volume":"141","author":"Bassez","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2025.116741_bib60","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ana.26713","article-title":"Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 Mice","volume":"94","author":"McLoughlin","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2025.116741_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.25264","article-title":"Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice","volume":"84","author":"McLoughlin","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2025.116741_bib62","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.ymthe.2024.02.033","article-title":"ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice","volume":"32","author":"Schuster","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celrep.2025.116741_bib63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.omtm.2022.04.004","article-title":"Combined overexpression of ATXN1L and mutant ATXN1 knockdown by AAV rescue motor phenotypes and gene signatures in SCA1 mice","volume":"25","author":"Carrell","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.celrep.2025.116741_bib64","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature22044","article-title":"Antisense oligonucleotide therapy for spinocerebellar ataxia type 2","volume":"544","author":"Scoles","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116741_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8677","article-title":"Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7","volume":"10","author":"Niu","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116741_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"Passini","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116741_bib67","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2025.116741_bib68","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116741_bib69","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116741_bib70","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI25424","article-title":"Antisense oligonucleotide therapy for neurodegenerative disease","volume":"116","author":"Smith","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116741_bib71","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1172\/JCI99081","article-title":"Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models","volume":"128","author":"McCampbell","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116741_bib72","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/d41573-021-00088-6","article-title":"Double setback for ASO trials in Huntington disease","volume":"20","author":"Kingwell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2025.116741_bib73","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s40120-023-00548-8","article-title":"Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD\/ALS Summit","volume":"12","author":"Sattler","year":"2023","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.celrep.2025.116741_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1042\/bse0540091","article-title":"The functions of natural antisense transcripts","volume":"54","author":"Wight","year":"2013","journal-title":"Essays Biochem."},{"key":"10.1016\/j.celrep.2025.116741_bib75","author":"Biogen"},{"key":"10.1016\/j.celrep.2025.116741_bib76","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","article-title":"Trinucleotide repeat disorders","volume":"30","author":"Orr","year":"2007","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.celrep.2025.116741_bib77","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.celrep.2025.116741_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109376","article-title":"Human oncoprotein 5MP suppresses general and repeat-associated non-AUG translation via eIF3 by a common mechanism","volume":"36","author":"Singh","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116741_bib79","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/mds.29183","article-title":"Repeat-Associated Non-AUG Translation of AGAGGG Repeats that Cause X-Linked Dystonia-Parkinsonism","volume":"37","author":"Reyes","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.celrep.2025.116741_bib80","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1248\/bpb.b22-00448","article-title":"Between Order and Chaos: Understanding the Mechanism and Pathology of RAN Translation","volume":"46","author":"Reyes","year":"2023","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.celrep.2025.116741_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02200-0","article-title":"RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response","volume":"8","author":"Green","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116741_bib82","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/s41467-017-02200-0","article-title":"RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response","volume":"8","author":"Green","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116741_bib83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41467-017-02495-z","article-title":"C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2alpha phosphorylation","volume":"9","author":"Cheng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116741_bib84","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.nbd.2018.05.009","article-title":"Translation of dipeptide repeat proteins from the C9ORF72 expanded repeat is associated with cellular stress","volume":"116","author":"Sonobe","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.celrep.2025.116741_bib85","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809423","article-title":"Repeat-associated non-AUG translation in C9orf72-ALS\/FTD is driven by neuronal excitation and stress","volume":"11","author":"Westergard","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.celrep.2025.116741_bib86","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/ncomms6659","article-title":"The role of protein clearance mechanisms in organismal ageing and age-related diseases","volume":"5","author":"Vilchez","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116741_bib87","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s43587-021-00112-9","article-title":"Perspective: Modulating the integrated stress response to slow aging and ameliorate age-related pathology","volume":"1","author":"Derisbourg","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.celrep.2025.116741_bib88","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fendo.2018.00790","article-title":"Hallmarks of Aging: An Autophagic Perspective","volume":"9","author":"Barbosa","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.celrep.2025.116741_bib89","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/gtc.13113","article-title":"Changes in brain proteasome dynamics associated with aging","volume":"29","author":"Nago","year":"2024","journal-title":"Genes Cells"},{"key":"10.1016\/j.celrep.2025.116741_bib90","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/138920291501140306113344","article-title":"The Mechanistic Links Between Proteasome Activity, Aging and Age-related Diseases","volume":"15","author":"Saez","year":"2014","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.celrep.2025.116741_bib91","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00415-018-9076-4","article-title":"Spinocerebellar ataxia: an update","volume":"266","author":"Sullivan","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.celrep.2025.116741_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087405","article-title":"Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics","volume":"24","author":"Paulino","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2025.116741_bib93","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-010-0717-7","article-title":"Axonal inclusions in spinocerebellar ataxia type 3","volume":"120","author":"Seidel","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.116741_bib94","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1093\/hmg\/ddaa279","article-title":"Repeat length increases disease penetrance and severity in C9orf72 ALS\/FTD BAC transgenic mice","volume":"29","author":"Pattamatta","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2025.116741_bib95","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.neuron.2022.01.006","article-title":"Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice","volume":"110","author":"Gu","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib96","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ng1827","article-title":"Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8","volume":"38","author":"Moseley","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2025.116741_bib97","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.2147\/CMAR.S257966","article-title":"Metformin Induces Autophagy via the AMPK-mTOR Signaling Pathway in Human Hepatocellular Carcinoma Cells","volume":"12","author":"Gao","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.celrep.2025.116741_bib98","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fendo.2018.00400","article-title":"The Therapeutic Potential of Metformin in Neurodegenerative Diseases","volume":"9","author":"Rotermund","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.celrep.2025.116741_bib99","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0092-8674(95)90273-2","article-title":"SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat","volume":"82","author":"Burright","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116741_bib100","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.neuron.2018.02.013","article-title":"ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism","volume":"97","author":"Rousseaux","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib101","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/40153","article-title":"Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures","volume":"389","author":"Skinner","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116741_bib102","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.neuron.2019.01.011","article-title":"A Selectivity Filter Gate Controls Voltage-Gated Calcium Channel Calcium-Dependent Inactivation","volume":"101","author":"Abderemane-Ali","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116741_bib103","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2025.116741_bib104","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2025.116741_bib105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2009.09.014","article-title":"Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Abeta peptides in mouse models of Alzheimer's disease","volume":"1301","author":"Christensen","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.celrep.2025.116741_bib106","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1369\/0022155412456379","article-title":"Enhanced antigen retrieval of amyloid beta immunohistochemistry: re-evaluation of amyloid beta pathology in Alzheimer disease and its mouse model","volume":"60","author":"Kai","year":"2012","journal-title":"J. Histochem. Cytochem."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472501513X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472501513X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:19:38Z","timestamp":1791260378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221112472501513X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S221112472501513X"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116741","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.10.14.682372","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeat-associated non-AUG translation as a common mechanism for the polyGln ataxias","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116741"}}